Results 181 to 190 of about 1,987,016 (297)

COVID-19 Transmission Potential and Non-Pharmaceutical Interventions in Maine During the COVID-19 Pandemic. [PDF]

open access: yesPathogens
Lee IS   +6 more
europepmc   +1 more source

Drug Delivery Technologies for the Treatment of Age‐Related Macular Degeneration

open access: yesAdvanced Science, EarlyView.
There are multiple therapeutic agents available for the treatment of both dry age‐related macular degeneration (AMD) and wet AMD. It is essential to continue innovation by introducing new drug delivery technologies that can incorporate those along with patient compliance and the accessibility of the technology into the early stages of research and ...
J Jesus Rodriguez‐Cruz   +4 more
wiley   +1 more source

Public health challenges posed by delays in obtaining COVID-19 clearance for long-distance truckers across East Africa

open access: yesGlobal Epidemiology, 2020
John Gachohi   +27 more
doaj   +1 more source

Younger Brazilians hit by COVID-19 – What are the implications?

open access: yesThe Lancet Regional Health. Americas, 2021
Raphael Mendonça Guimarães, DSc PhD   +4 more
doaj   +1 more source

COVID-19 Vaccine-Induced Severe Pneumonitis. [PDF]

open access: yesRespirol Case Rep
Suzuki T   +6 more
europepmc   +1 more source

CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics

open access: yesAdvanced Science, EarlyView.
CellPhenoX is an explainable machine learning framework that identifies cell‐specific phenotypes and interaction effects from single‐cell omics data. By leveraging interpretable models, it enables robust discovery of cell‐level phenotypes that contribute to clinical outcomes.
Jade Young   +4 more
wiley   +1 more source

The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation

open access: yesAdvanced Science, EarlyView.
ZBP1 is capable of initiating a large cell death complex to induce programmed cell death during SARS‐CoV‐2 infection. However, SARS‐CoV‐2 can inhibit the activation of ZBP1‐mediated cell death by targeting key components of this complex. This suppression of ZBP1‐mediated cell death may account for the increased mortality observed in patients co ...
Huan Wang   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy